YUCE BIOLOGICAL TECHNOLOGY
Shenzhen Yuce Biotechnology Co., Ltd. focuses on genetic testing services for tumor precision immunotherapy, with "gene" + "immunity" as its wings, organically combining tumor genome and immune microenvironment.
YUCE BIOLOGICAL TECHNOLOGY
Social Links:
Industry:
Biotechnology Health Care Oncology
Founded:
2015-01-01
Status:
Active
Contact:
400-9958-139
Email Addresses:
[email protected]
Total Funding:
62.82 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Content Delivery Network LetsEncrypt SSL By Default Mobile Non Scaleable Content Nginx Cloudflare JS CDN JS
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Nueclear Healthcare
Nueclear Healthcare is the low-cost cancer diagnosis services business of the Thyrocare group
Oncora Medical
Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Pleno
Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Founder
Investors List
Tzitzit Aseet
Tzitzit Aseet investment in Series C - Yuce Biological Technology
Breakthrough Capital
Breakthrough Capital investment in Series C - Yuce Biological Technology
Pearl River Investment
Pearl River Investment investment in Series C - Yuce Biological Technology
Yuanzhi Technology Group
Yuanzhi Technology Group investment in Series C - Yuce Biological Technology
IDG Capital
IDG Capital investment in Series B - Yuce Biological Technology
Bioclub
Bioclub investment in Series A - Yuce Biological Technology
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-01-17 | MabPlex International | Yuce Biological Technology investment in Series A - MabPlex International | 400 M CNY |
More informations about "Yuce Biological Technology"
Yuce Biological Technology - Crunchbase
Yuce Biological Technology raised $43,000,000 / Series C from Pearl River Investment and Yuanzhi Technology Group Discover more funding rounds โฆSee details»
Yuce Biological Technology - Funding, Financials, Valuation
Yuce Biological Technology is a biotechnology developer which focuses on cancer diagnosis through gene detection. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. โฆSee details»
YuCe Bio 2025 Company Profile: Valuation, Funding & Investors
YuCe Bio General Information Description. Provider of gene detection services for tumor precision immunotherapy. The company's genetic testing products of Yuce One Plus and Yuce One ICIs โฆSee details»
Yuce Biological Technology - Investments, Portfolio & Company โฆ
Jan 17, 2019 Yuce Biological Technology is a biotechnology developer which focuses on cancer diagnosis through gene detection. New. Resources. Advanced Search. Start Free Trial . Talk โฆSee details»
Yuce Biological Technology - Overview, News & Similar
Yuce Biological Technology. Business Services · China · <25 Employees. Yuce Biological Technology is a company that operates in the Biotechnology industry. It employs 21-50 people โฆSee details»
Yuce Bio Snares ๏ฟฅ300M in Series C Financing - vbdata.cn
Aug 25, 2020 According to VCBeat, Shenzhen Yuce Biological Technology Co., Ltd. ("Yuce Bio") recently announced the completion of a ๏ฟฅ300 million Series C financing, led by Yuanzhi Science & Technology Medical, with participation โฆSee details»
Yuce Biological Technology | Company | Mindmaps
Company โ «Yuce Biological Technology» Yuce Biological ... Estimated Revenue: $5M-$10MYuce Biological Technology. Last Funding Type: Series C. Technology: diagnostics. โฆSee details»
Yuce Bio Completes $43 Million Funding for Clinical Cancer ...
Aug 25, 2020 Shenzhen Yuce Biological completed a $43 million Series C round led by Yuanzhi Science & Technology Medical for its clinical testing of cancer immunotherapies. Yuce Bio has โฆSee details»
Yuce Bio Company Profile - Office Locations, Competitors ... - Craft
Yuce Bio is a company that provides gene detection services for tumor precision immunotherapy. Its genetic testing products Yuce One Plus and Yuce One ICIs offer genetic testing and โฆSee details»
Yuce Biological Technology - Tech Stack, Apps, Patents
Yuce Biological Technology is a biotechnology developer which focuses on cancer diagnosis through gene detection. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. โฆSee details»
Yuce Biological Technology โ 1 Portfolio companies, 1 โฆ
In 2015 was created Yuce Biological Technology, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in China. The leading representative office of โฆSee details»
Yuce Biological Technology | Detailed Analysis of Terms and Deals
Learn about Yuce Biological Technology's main interests, whether their terms are better or worse compared to the market average, and much more. Top VC Funds. About. Favorites. Go back. โฆSee details»
Yuce Biological Technology - Golden
Canonical knowledge wiki about Yuce Biological Technology. Canonical knowledge wiki about Yuce Biological Technology ... Yuce Biological Technology. Overview Structured Data Issues โฆSee details»
IDG Leads Yuce Biologicalโs Hundreds of Millions Series B Funding
On December 10, 2018, Yuce Biological Technology(่ฃ็ญ็็ฉ, YuceBio) completed series B funding led by IDG with hundreds of millions yuan according to someone familiar with the โฆSee details»
Yuce Biological Technology - CoBee Company Profile & Funding โฆ
Yuce Biological Technology. Yuce Biological Technology is a biotechnology developer which focuses on cancer diagnosis through gene detection. Business Model: Revenue: $0. โฆSee details»
Yuce Bio Completes $43 Million Funding for Clinical Cancer ...
On August 25, 2020 Shenzhen Yuce Biological reported that completed a $43 million Series C round led by Yuanzhi Science & Technology Medical for its clinical testing of cancer โฆSee details»
Yuce Biological Technology โ China Money Network
China Venture Capital, Private Equity and Primary Market Data, News and Insights โ China Money NetworkSee details»
Series C - Yuce Biological Technology - 2021-11-11 - Crunchbase
Yuce Biological Technology raised $14083185 on 2021-11-11 in Series C. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log โฆSee details»
IDG Capital Backs Shenzhen-Based Biotech Firm Yuce Bio In Series โฆ
Dec 11, 2018 Shenzhen-based Biotech firm Yuce Biological Technology has completed a series B round led by IDG Capital, as biotech booms in China. The specific amount ... biotech, car, โฆSee details»
Yuce Biological Technology - Contacts, Employees, Board โฆ
Yuce Biological Technology is a biotechnology developer which focuses on cancer diagnosis through gene detection. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. โฆSee details»